Mehran Karimi

Dr. Mehran Karimi is a Professor Emeritus of Pediatric Hematology and Oncology. He is an Iranian board-certified specialist in pediatric hematology-oncology with working experience in the field of hemophilia, rare bleeding disorders, hemoglobin disorders, benign pediatric hematology disorders, pediatric solid tumors, and leukemia/lymphoma for more than 28 years. He has also practiced in Dubai as a pediatric hematologist-oncologist since 2012. He had a 6-month fellowship in pediatric bone marrow transplantation in 1995-1996 in Leeds, UK, two separate 3-month hemostasis and thrombosis fellowships in Milan, Italy in 2001 & 2003, and one year as a research scientist at IHTC in Indianapolis, USA from 2016-2017. He authored more than 400 articles and more than 350 abstracts in peer-reviewed journals and has been invited as a speaker at many national and international conferences. He has been as a professor lecturing since 1998 and got Razi Festival Award as a best researcher in 2003 and 2008 and 15th Abu Reyhan Biruni Research Festival Award in 2014 in Iran.

Spoken Languages : English, Farsi
Types of Physician : Full-time
DHA License : Consultant Pediatric Hematologist-Oncologist
Branches : American Hospital Dubai


  • Pediatric Hematology Oncology, Shiraz and Ahvaz Universities of Medical Sciences, Iran
  • Pediatric Bone Marrow Fellowship, Leeds University, UK
  • Hemostasis and thrombosis fellowship, Milan University, Italy

Professional Associations:

  • ISTH member (International Society of Thrombosis and Hemostasis)
  • ICET-A member (the International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence)
  • Scientific collaborator of TIF (Thalassemia International Federation)

Professional Experience:

  • Pediatric Hematology-Oncology, Iranian Hospital, UAE
  • Professor of Pediatric Hematology-Oncology, Shiraz University of Medical Sciences, Iran
  • Research Physician (Hematologist), IHTC, USA

Clinical Expertise & Services Offered:

  • Hemoglobinopathies (Thalassemia and sickle cell disease, etc.),
  • Hemostasis and thrombosis disorders (hemophilia, von Willbrand disease, rare bleeding disorders and hereditary platelet function disorders)
  • Benign pediatric hematology disorders (ITP, Iron deficiency anemia, HLH, Aplastic anemia, hemolytic anemia, HUS/TTP, G6PD deficiency, Spherocytosis
  • Solid tumors (Brain tumors, Wilms tumor, Neuroblastoma, Osteosarcoma, Ewing sarcoma, Retinoblastoma, Hepatoblastoma, Soft tissue sarcoma (Rhabdomyosarcoma), Germ cell tumors
  • Leukemia/lymphoma, Histiocytosis